Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
43
GNOM Quote, Financials, Valuation and Earnings
Last price:
$8.64
Seasonality move
:
-8.1%
Day range:
$8.69 - $8.78
52-week range:
$6.80 - $11.88
Dividend yield:
0.1%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
35.6K
Avg. volume:
48.9K
1-year change:
-24.82%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
COPJ
Sprott Junior Copper Miners ETF
|
-- | -- | -- | -- | -- |
|
CTEC
Global X CleanTech ETF
|
-- | -- | -- | -- | -- |
|
HEAL
Global X HealthTech ETF
|
-- | -- | -- | -- | -- |
|
HYDR
Global X Hydrogen ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GNOM
Global X Genomics & Biotechnology ETF
|
$8.72 | -- | -- | -- | $0.01 | 0.1% | -- |
|
AGNG
Global X Aging Population ETF
|
$32.20 | -- | -- | -- | $0.14 | 0.9% | -- |
|
COPJ
Sprott Junior Copper Miners ETF
|
$25.99 | -- | -- | -- | $2.15 | 8.27% | -- |
|
CTEC
Global X CleanTech ETF
|
$8.09 | -- | -- | -- | $0.02 | 1.29% | -- |
|
HEAL
Global X HealthTech ETF
|
$10.44 | -- | -- | -- | $0.01 | 0.08% | -- |
|
HYDR
Global X Hydrogen ETF
|
$23.51 | -- | -- | -- | $0.26 | 1.51% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 1.725 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.588 | -- | -- |
|
COPJ
Sprott Junior Copper Miners ETF
|
-- | 0.552 | -- | -- |
|
CTEC
Global X CleanTech ETF
|
-- | 1.647 | -- | -- |
|
HEAL
Global X HealthTech ETF
|
-- | 2.066 | -- | -- |
|
HYDR
Global X Hydrogen ETF
|
-- | 3.196 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
COPJ
Sprott Junior Copper Miners ETF
|
-- | -- | -- | -- | -- | -- |
|
CTEC
Global X CleanTech ETF
|
-- | -- | -- | -- | -- | -- |
|
HEAL
Global X HealthTech ETF
|
-- | -- | -- | -- | -- | -- |
|
HYDR
Global X Hydrogen ETF
|
-- | -- | -- | -- | -- | -- |
Global X Genomics & Biotechnology ETF vs. Competitors
-
Which has Higher Returns GNOM or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Global X Genomics & Biotechnology ETF's net margin of --. Global X Genomics & Biotechnology ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GNOMGlobal X Genomics & Biotechnology ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About GNOM or AGNG?
Global X Genomics & Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Genomics & Biotechnology ETF has higher upside potential than Global X Aging Population ETF, analysts believe Global X Genomics & Biotechnology ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings GNOMGlobal X Genomics & Biotechnology ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is GNOM or AGNG More Risky?
Global X Genomics & Biotechnology ETF has a beta of 1.197, which suggesting that the stock is 19.747% more volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.736, suggesting its less volatile than the S&P 500 by 26.45%.
-
Which is a Better Dividend Stock GNOM or AGNG?
Global X Genomics & Biotechnology ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.1%. Global X Aging Population ETF offers a yield of 0.9% to investors and pays a quarterly dividend of $0.14 per share. Global X Genomics & Biotechnology ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GNOM or AGNG?
Global X Genomics & Biotechnology ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Global X Genomics & Biotechnology ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Global X Genomics & Biotechnology ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Genomics & Biotechnology ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns GNOM or COPJ?
Sprott Junior Copper Miners ETF has a net margin of -- compared to Global X Genomics & Biotechnology ETF's net margin of --. Global X Genomics & Biotechnology ETF's return on equity of -- beat Sprott Junior Copper Miners ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GNOMGlobal X Genomics & Biotechnology ETF-- -- -- COPJSprott Junior Copper Miners ETF-- -- -- -
What do Analysts Say About GNOM or COPJ?
Global X Genomics & Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Sprott Junior Copper Miners ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Genomics & Biotechnology ETF has higher upside potential than Sprott Junior Copper Miners ETF, analysts believe Global X Genomics & Biotechnology ETF is more attractive than Sprott Junior Copper Miners ETF.
Company Buy Ratings Hold Ratings Sell Ratings GNOMGlobal X Genomics & Biotechnology ETF0 0 0 COPJSprott Junior Copper Miners ETF0 0 0 -
Is GNOM or COPJ More Risky?
Global X Genomics & Biotechnology ETF has a beta of 1.197, which suggesting that the stock is 19.747% more volatile than S&P 500. In comparison Sprott Junior Copper Miners ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GNOM or COPJ?
Global X Genomics & Biotechnology ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.1%. Sprott Junior Copper Miners ETF offers a yield of 8.27% to investors and pays a quarterly dividend of $2.15 per share. Global X Genomics & Biotechnology ETF pays -- of its earnings as a dividend. Sprott Junior Copper Miners ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GNOM or COPJ?
Global X Genomics & Biotechnology ETF quarterly revenues are --, which are smaller than Sprott Junior Copper Miners ETF quarterly revenues of --. Global X Genomics & Biotechnology ETF's net income of -- is lower than Sprott Junior Copper Miners ETF's net income of --. Notably, Global X Genomics & Biotechnology ETF's price-to-earnings ratio is -- while Sprott Junior Copper Miners ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Genomics & Biotechnology ETF is -- versus -- for Sprott Junior Copper Miners ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -- COPJSprott Junior Copper Miners ETF-- -- -- --
-
Which has Higher Returns GNOM or CTEC?
Global X CleanTech ETF has a net margin of -- compared to Global X Genomics & Biotechnology ETF's net margin of --. Global X Genomics & Biotechnology ETF's return on equity of -- beat Global X CleanTech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GNOMGlobal X Genomics & Biotechnology ETF-- -- -- CTECGlobal X CleanTech ETF-- -- -- -
What do Analysts Say About GNOM or CTEC?
Global X Genomics & Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X CleanTech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Genomics & Biotechnology ETF has higher upside potential than Global X CleanTech ETF, analysts believe Global X Genomics & Biotechnology ETF is more attractive than Global X CleanTech ETF.
Company Buy Ratings Hold Ratings Sell Ratings GNOMGlobal X Genomics & Biotechnology ETF0 0 0 CTECGlobal X CleanTech ETF0 0 0 -
Is GNOM or CTEC More Risky?
Global X Genomics & Biotechnology ETF has a beta of 1.197, which suggesting that the stock is 19.747% more volatile than S&P 500. In comparison Global X CleanTech ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GNOM or CTEC?
Global X Genomics & Biotechnology ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.1%. Global X CleanTech ETF offers a yield of 1.29% to investors and pays a quarterly dividend of $0.02 per share. Global X Genomics & Biotechnology ETF pays -- of its earnings as a dividend. Global X CleanTech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GNOM or CTEC?
Global X Genomics & Biotechnology ETF quarterly revenues are --, which are smaller than Global X CleanTech ETF quarterly revenues of --. Global X Genomics & Biotechnology ETF's net income of -- is lower than Global X CleanTech ETF's net income of --. Notably, Global X Genomics & Biotechnology ETF's price-to-earnings ratio is -- while Global X CleanTech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Genomics & Biotechnology ETF is -- versus -- for Global X CleanTech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -- CTECGlobal X CleanTech ETF-- -- -- --
-
Which has Higher Returns GNOM or HEAL?
Global X HealthTech ETF has a net margin of -- compared to Global X Genomics & Biotechnology ETF's net margin of --. Global X Genomics & Biotechnology ETF's return on equity of -- beat Global X HealthTech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GNOMGlobal X Genomics & Biotechnology ETF-- -- -- HEALGlobal X HealthTech ETF-- -- -- -
What do Analysts Say About GNOM or HEAL?
Global X Genomics & Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X HealthTech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Genomics & Biotechnology ETF has higher upside potential than Global X HealthTech ETF, analysts believe Global X Genomics & Biotechnology ETF is more attractive than Global X HealthTech ETF.
Company Buy Ratings Hold Ratings Sell Ratings GNOMGlobal X Genomics & Biotechnology ETF0 0 0 HEALGlobal X HealthTech ETF0 0 0 -
Is GNOM or HEAL More Risky?
Global X Genomics & Biotechnology ETF has a beta of 1.197, which suggesting that the stock is 19.747% more volatile than S&P 500. In comparison Global X HealthTech ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GNOM or HEAL?
Global X Genomics & Biotechnology ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.1%. Global X HealthTech ETF offers a yield of 0.08% to investors and pays a quarterly dividend of $0.01 per share. Global X Genomics & Biotechnology ETF pays -- of its earnings as a dividend. Global X HealthTech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GNOM or HEAL?
Global X Genomics & Biotechnology ETF quarterly revenues are --, which are smaller than Global X HealthTech ETF quarterly revenues of --. Global X Genomics & Biotechnology ETF's net income of -- is lower than Global X HealthTech ETF's net income of --. Notably, Global X Genomics & Biotechnology ETF's price-to-earnings ratio is -- while Global X HealthTech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Genomics & Biotechnology ETF is -- versus -- for Global X HealthTech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -- HEALGlobal X HealthTech ETF-- -- -- --
-
Which has Higher Returns GNOM or HYDR?
Global X Hydrogen ETF has a net margin of -- compared to Global X Genomics & Biotechnology ETF's net margin of --. Global X Genomics & Biotechnology ETF's return on equity of -- beat Global X Hydrogen ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GNOMGlobal X Genomics & Biotechnology ETF-- -- -- HYDRGlobal X Hydrogen ETF-- -- -- -
What do Analysts Say About GNOM or HYDR?
Global X Genomics & Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Hydrogen ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Genomics & Biotechnology ETF has higher upside potential than Global X Hydrogen ETF, analysts believe Global X Genomics & Biotechnology ETF is more attractive than Global X Hydrogen ETF.
Company Buy Ratings Hold Ratings Sell Ratings GNOMGlobal X Genomics & Biotechnology ETF0 0 0 HYDRGlobal X Hydrogen ETF0 0 0 -
Is GNOM or HYDR More Risky?
Global X Genomics & Biotechnology ETF has a beta of 1.197, which suggesting that the stock is 19.747% more volatile than S&P 500. In comparison Global X Hydrogen ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GNOM or HYDR?
Global X Genomics & Biotechnology ETF has a quarterly dividend of $0.01 per share corresponding to a yield of 0.1%. Global X Hydrogen ETF offers a yield of 1.51% to investors and pays a quarterly dividend of $0.26 per share. Global X Genomics & Biotechnology ETF pays -- of its earnings as a dividend. Global X Hydrogen ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GNOM or HYDR?
Global X Genomics & Biotechnology ETF quarterly revenues are --, which are smaller than Global X Hydrogen ETF quarterly revenues of --. Global X Genomics & Biotechnology ETF's net income of -- is lower than Global X Hydrogen ETF's net income of --. Notably, Global X Genomics & Biotechnology ETF's price-to-earnings ratio is -- while Global X Hydrogen ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Genomics & Biotechnology ETF is -- versus -- for Global X Hydrogen ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -- HYDRGlobal X Hydrogen ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 3.83% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is down 0.18% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 3.81% over the past day.
